Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$16,000,397
+$12,905,371 QoQ
Shares Held
13,340
+296.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.08%
of 13F equity value
Holder Rank
#1,004
of 4,605 holders
Holding Since
Dec 2021
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Trivium Point Advisory, LLC holds $28,456,605 across 8 Drug Manufacturers - General names. LLY ranks #1 (56.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
13,340 | $16,000,397 | |
| 2 | JNJ |
Johnson & Johnson
|
12,027 | $3,054,497 | |
| 3 | ABBV |
AbbVie Inc.
|
10,728 | $2,699,593 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,671 | $2,270,723 | |
| 5 | AMGN |
Amgen Inc
|
3,478 | $1,259,453 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
20,481 | $1,180,115 | |
| 7 | PFE |
Pfizer Inc
|
45,408 | $1,093,424 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,111 | $898,403 |
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,000,397 | 13,340 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $3,095,026 | 3,365 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $4,080,560 | 3,797 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,857,435 | 3,745 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,312,085 | 2,966 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $2,372,839 | 2,873 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,003,340 | 2,595 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,409,530 | 1,591 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $418,285 | 462 | Shares | Sole | 2024-08-14 | |
| 2022-03-31 | $628,868 | 2,196 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $236,720 | 857 | Shares | Sole | 2022-02-18 | |
| No filing history on record for this holder in this stock. | ||||||